Corrigendum to “Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice” [MOLMET 85 (2024) 1–16]

• Joshua Adekunle Babalola,
• Anika Stracke,
• Tina Loeffler,
• Irene Schilcher,
• Spyridon Sideromenos,
• Stefanie Flunkert,
• Joerg Neddens,
• Ake Lignell,
• Manuela Prokesch,
• Ute Panzenboeck,
• Herbert Strobl,
• Jelena Tadic,
• Gerd Leitinger,
• Achim Lass,
• Birgit Hutter-Paier,
• Gerald Hoefler

Affiliations

Joshua Adekunle Babalola

D&F Institut für Pathologie Medizinische Universität Graz, Graz, Austria

Anika Stracke

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Austria

Tina Loeffler

QPS Austria GmbH, Grambach, Austria

Irene Schilcher

QPS Austria GmbH, Grambach, Austria

Spyridon Sideromenos

QPS Austria GmbH, Grambach, Austria; Medical University of Vienna, Vienna, Austria

Stefanie Flunkert

QPS Austria GmbH, Grambach, Austria

Joerg Neddens

QPS Austria GmbH, Grambach, Austria

Ake Lignell

AstaReal AB, Sweden

Manuela Prokesch

QPS Austria GmbH, Grambach, Austria

Ute Panzenboeck

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Austria

Herbert Strobl

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Austria

Jelena Tadic

Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria

Gerd Leitinger

Institute of Molecular Biosciences, University of Graz, Austria

Achim Lass

Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Austria

Birgit Hutter-Paier

QPS Austria GmbH, Grambach, Austria

Gerald Hoefler

D&F Institut für Pathologie Medizinische Universität Graz, Graz, Austria; Corresponding author. D&F Institut für Pathologie Medizinische Universität Graz, Graz, Austria.